BASEL, Switzerland — Novartis announced Sunday that it is recalling a number of over-the-counter drugs, including certain bottles of Excedrin and Bufferin, due to complaints about chipped and broken pills and inconsistent bottle packaging, according to a press release.
The drug maker is taking this action as a precautionary measure, because the products may contain stray tablets, capsules or caplets from other Novartis products, or contain broken or chipped tablets.
This precautionary recall follows the recent voluntary suspension of operations and shipments from Novartis Consumer Health Inc.''s Lincoln, Neb., facility.
"We are committed to a single quality standard for the entire Novartis Group and we are making the necessary investments and committing the right resources to ensure these are implemented across our entire network," said Joseph Jimenez, CEO of Novartis. "The high quality of our products and operations has been critical to building the Novartis reputation over the past 15 years. We are committed to ensuring the highest standard for patients who rely on our products and medicines."